Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Most Shorted Stocks
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Investors
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
MCP for Agents
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Most Shorted Stocks
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Center
Investors
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
RCUS
Stock Latest News
Ratings
Arcus Maintained at Hold as Balanced Risk-Reward Persists; $29 Price Target Reaffirmed
52m ago
RCUS
Premium
The Fly
Mizuho biotech analysts hold an analyst/industry conference call
4d ago
BBIO
BIIB
Premium
Ratings
Analyst Reiterates Buy on Arcus Biosciences, Maintains $46 Price Target Amid Optimism for Casdatifan Triplet Regimen
8d ago
RCUS
Premium
The Fly
Arcus Biosciences to host investor event on casdatifan data
13d ago
RCUS
Premium
The Fly
Arcus Biosciences initiated with a Buy at TD Cowen
19d ago
RCUS
Premium
Ratings
Arcus Buy Rating Reiterated as Casdatifan Data Catalysts Approach; Price Target Maintained at $46
22d ago
RCUS
Premium
Company Announcements
Arcus Biosciences Nears Key Data Milestone in Pancreatic Cancer Trial
26d ago
RCUS
Premium
The Fly
Arcus Biosciences price target raised to $40 from $35 at Truist
27d ago
RCUS
Premium
Company Announcements
Arcus Biosciences Advances Casdatifan With New Liver Function Study
1M ago
RCUS
Premium
Company Announcements
Arcus Biosciences Bets Big on Casdatifan Pipeline
2M ago
RCUS
Premium
Company Announcements
Arcus Biosciences Locks In Key Casdatifan Data With Completed Phase 1 Study
2M ago
RCUS
Premium
The Fly
Arcus Biosciences price target raised to $23 from $22 at Morgan Stanley
2M ago
RCUS
Premium
The Fly
Arcus Biosciences price target raised to $42 from $34 at Goldman Sachs
2M ago
RCUS
Premium
Ratings
Salim Syed Initiates Buy on Arcus, Citing Casdatifan’s Foundational RCC Potential and Diversified Late-Stage Pipeline Ahead of 2026 Inflection Data
2M ago
RCUS
Premium
The Fly
Arcus Biosciences price target raised to $43 from $41 at Wedbush
2M ago
RCUS
Premium
The Fly
Arcus Biosciences price target raised to $26 from $23 at Wells Fargo
2M ago
RCUS
Premium
Ratings
Arcus Biosciences: Broad Casdatifan Strategy in ccRCC Supports Buy Rating with Unchanged $45 Price Target
2M ago
RCUS
Premium
The Fly
Arcus Biosciences reports Q2 EPS (72c), consensus (81c)
2M ago
RCUS
Premium
The Fly
Arcus Biosciences price target raised to $29 from $25 at BofA
2M ago
RCUS
Premium
Ratings
Buy Rating Reaffirmed on Arcus Biosciences as New RCC Partnerships Strengthen Multi-Line Development Strategy
2M ago
RCUS
Premium
The Fly
Arcus, Summit enter into clinical trial collaboration over kidney cancer
2M ago
RCUS
SMMT
Premium
The Fly
Arcus Biosciences announces clinical supply pact with AVEO Oncology
2M ago
RCUS
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.